Workflow
PTC(PTC)
icon
搜索文档
PTC Therapeutics Announces Sepiapterin NDA Submission to FDA
Prnewswire· 2024-07-30 20:00
"This NDA submission is an important step in bringing this therapy to children and adults living with PKU in the U.S.," said Matthew B. Klein, M.D., Chief Executive Officer of PTC Therapeutics. "The robust sepiapterin clinical trial data, including Phe tolerance results, support the potential of sepiapterin to meet the persistent unmet medical need for the large number of children and adults with PKU." The European marketing authorization application is currently under review and the marketing authorization ...
PTC Gears Up to Report Q3 Earnings: What's in the Offing?
ZACKS· 2024-07-29 22:40
公司财报预期 - PTC公司计划于2024财年第三季度财报在7月31日收盘后发布 [1] - 市场对PTC公司第三季度营收的共识预期为5.33亿美元,较去年同期下降1.7% [2] - 每股收益的共识预期为0.98美元,同比下降1% [2] - 公司在过去四个季度中有三次超出Zacks共识预期,平均超预期8.8% [3] 公司业绩展望 - PTC公司预计第三季度营收在5.25亿至5.4亿美元之间 [4] - 非GAAP每股收益预计在0.9至1美元之间 [4] - 公司预计年度经常性收入(ARR)在21.15亿至21.3亿美元之间 [9] - 预计运营现金流为2.25亿美元,自由现金流为2.2亿美元 [9] 业务驱动因素 - PTC的核心业务部门——计算机辅助设计(CAD)和产品生命周期管理(PLM)解决方案——仍然是主要收入驱动因素 [5] - Windchill软件在多个行业的健康采用预计推动了PTC的营收表现 [6] - 公司正在整合Codebeamer和Windchill以简化软件和硬件配置管理 [6] - Creo和其他CAD设计工具的产品更新和创新预计贡献了营收 [6] - 新兴技术如物联网(IoT)、增强现实(AR)和人工智能(AI)的投资与行业趋势一致 [7] 战略合作伙伴关系 - PTC与Trax在2024年4月合作,整合Trax的平台与PTC的Servigistics,旨在设计独特的联合解决方案,提高效率并现代化服务供应链优化 [8] 潜在挑战 - 不利的外汇波动和全球宏观经济疲软可能成为阻力 [10] - 增加研发成本以应对PLM和CAD领域的激烈竞争可能对利润率表现产生压力 [10] 模型预测 - 根据模型预测,PTC此次财报有望超出预期,因其Earnings ESP为+1.47%,且Zacks排名为3 [12] 其他公司 - Pinterest(PINS)计划于7月30日发布季度财报,Earnings ESP为+7.14%,Zacks排名为3 [14] - Silicon Motion Technology Corporation(SIMO)计划于8月1日发布季度财报,Earnings ESP为+2.66%,Zacks排名为1 [16] - Arista Networks, Inc.(ANET)计划于7月30日发布季度财报,Earnings ESP为+1.72%,Zacks排名为1 [18]
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results
Prnewswire· 2024-07-26 04:30
WARREN, N.J., July 25, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its second quarter 2024 financial results and provide an update on the company's business and outlook on Thursday, Aug. 8, at 4:30 p.m. EDT. To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in to the conference call 15 minutes prior to the start ...
Why PTC Inc. (PTC) Could Beat Earnings Estimates Again
ZACKS· 2024-07-20 01:16
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? PTC Inc. (PTC) , which belongs to the Zacks Computer - Software industry, could be a great candidate to consider. For the last reported quarter, PTC Inc. Came out with earnings of $1.46 per share versus the Zacks Consensus Estimate of $1.23 per share, representing a surprise of 18.70%. For the previous quarter, the company was expected to post earnings ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
GlobeNewswire News Room· 2024-07-13 03:20
[Click here for information about joining the class action] Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for th ...
PTC: A Bullish Bet With ServiceMax Integration Boost
Seeking Alpha· 2024-07-13 03:02
Investment Outlook Despite a challenging sales environment for transformational deals, the company has produced revenue and earnings growth as it works to maximize value from its 2023 acquisition of ServiceMax. While PTC Inc. stock isn't cheap, my outlook is a Buy at around $180 per share. A 2022 market research report by Grand View Research estimates the global market for product lifecycle management [PLM] accounted for $26.9 billion in 2021 market value, and was expected to exceed $56 billion by 2030. If ...
PTC to Announce Fiscal Q3'24 Results on Wednesday, July 31st, 2024
Prnewswire· 2024-07-11 20:00
When: Wednesday, July 31st, 5:00pm (ET) Please note that statements made on the conference call and webcast are as of the date of the conference call and webcast and PTC does not assume any obligation to update any statements made live or the archived call. Matters discussed may include forward-looking statements about PTC's anticipated financial results and growth, as well as about the development of products and markets, which are based on current plans and assumptions. Actual results in future periods ma ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
Prnewswire· 2024-07-03 04:54
NEW YORK, July 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. [Click here for information about joining the class action] On this news, PTC's stock price fell $4.08 per share, or 11.77%, to close at $30.58 per share on June 28, 2024. Attorney advertising. Prior results do not guarantee similar outcomes. ...
3 Robotics Stocks That Could Make Your Grandchildren Rich
Investor Place· 2024-06-28 21:30
文章核心观点 - 机器人行业市场规模有望从2024年的$45.85亿增长到2029年的$95.93亿,增长率达15.91% [1] - 美国机器人行业市场规模有望在2024年达到$7.85亿,成为全球最大市场 [1] - 机器人行业受到机构投资者的青睐,主要得益于拜登总统2024年颁布的人工智能行政命令,旨在推进人工智能技术的发展,确保其安全性、安全性和公平性 [2] - 机器人技术正在不断进步,如NVIDIA、比亚迪和Teradyne的合作使机器人具备自主驾驶、协作等人工智能和建模能力 [2] - 人形机器人正在改善医疗和工作环境,如亚马逊和宝马使用这些机器人来执行危险或重复性的任务,提高安全性和效率 [3] - 工业外骨骼预计到2030年将增长7倍,帮助工人在搬运重物或重复活动时避免损伤和疲劳 [4] 行业发展 - 机器人行业市场规模有望从2024年的$45.85亿增长到2029年的$95.93亿,增长率达15.91% [1] - 美国机器人行业市场规模有望在2024年达到$7.85亿,成为全球最大市场 [1] - 机器人技术正在不断进步,如NVIDIA、比亚迪和Teradyne的合作使机器人具备自主驾驶、协作等人工智能和建模能力 [2] - 人形机器人正在改善医疗和工作环境,如亚马逊和宝马使用这些机器人来执行危险或重复性的任务,提高安全性和效率 [3] - 工业外骨骼预计到2030年将增长7倍,帮助工人在搬运重物或重复活动时避免损伤和疲劳 [4] 公司发展 Teradyne (TER) - Teradyne是一家测试机器人和工业自动化的领先公司,过去12个季度每个季度的收益都超过预期,并且在工业机器人市场份额持续增长 [6] - Teradyne 2024年第一季度业绩强劲,营收达$599.82亿,超过预期$566.31亿;每股收益51美分,也超过预期33美分 [7] - Teradyne已经发货8,000台J750动力测试设备,这一里程碑显示了公司在半导体测试和自主测试能力方面的专长 [8] - Teradyne正在通过与NVIDIA的合作,将人工智能技术应用于其机器人产品,如Universal Robots和MiR1200托盘搬运车,提升路径规划和自主导航能力 [9] - Teradyne新任命的首席人工智能官James Davidson,其在人工智能和机器人领域的专业知识,可能会为公司的移动机器人业务带来新的想法 [10] Symbotic (SYM) - Symbotic提供仓库自动化解决方案,其基于人工智能的供应链机器人技术,使其过去4个季度的利润超预期801%至901% [12] - Symbotic 2024财年第二季度营收达$424.3亿,超过预期$412.9亿,但每股亏损7美分,未达预期5美分盈利 [13] - 分析师预计Symbotic 2024财年每股利润将从2美分上调至40美分,并给予其买入评级,主要得益于收入和毛利率的增长 [14] - Symbotic不断改进和拓展产品,如GreenBox联合项目和BreakPack解决方案,以保持利润增长势头,并帮助公司拓展更多客户 [15] - 凭借其技术创新和快速增长,Symbotic被评为2024年全球最具创新力公司之一 [16] PTC (PTC) - PTC是计算机辅助设计领域的领导者,提供3D、VR和AR等仿真软件,连续8年实现盈利,是一家值得关注的机器人股票 [17] - PTC 2024年第二季度每股收益$1.10,超过预期$0.87;营收$603.07亿,也超过预期$575.53亿 [17] - PTC在2,279家公司中排名前32%,显示其在竞争激烈的领域具有竞争优势和稳定性,分析师给予其强烈买入评级,12个月目标价约为$191,较当前价格$178高8% [18] - PTC在工业物联网、CAD等多个领域获得行业权威机构的认可,如连续5年获得Quadrant Knowledge Solutions的IIoT SPARK Matrix第一名 [19] - PTC的Windchill和Codebeamer等工具被大众汽车集团等大型企业广泛应用于工程和产品生命周期管理 [20]
1 Long-Term Growth Stock to Buy Hand Over Fist and 1 to Avoid
The Motley Fool· 2024-06-27 18:51
However, there are two crucial differences between the companies right now. Full-Year 2024 Guidance In November In January In May Reported sales growth 0.5% to 6.5% 0.5% to 6.5% (4%) to (6%) Organic sales growth (2%) to 4% (2%) to 4% (6%) to (8%) Adjusted EPS $12-$13.50 $12-$13.50 $10-$11 A more resilient business model Another reason to favor PTC is its more resilient business model. For example, it's harder for Rockwell to cut costs in a downturn, meaning that its profit margin will dip when sales start t ...